Global Biologics Market By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi), By Region, Industry Analysis, Share, Growth, Trends, and Forecast, 2021-2028

Covid-19 Impact on Global Biologics Market

Type: PDF

Status: Published

Categories: Pharma & Healthcare

Report Code : PHC214006

No. of Pages : 275

The global biologics market is expected to grow from USD 274.8 billion in 2020 to USD 497.53 billion by 2028 at a CAGR of 7.7 % over the forecast period 2021-2028.

Market Overview:

A biologic is developed in a living system like a microorganism or plant or animal cells. Many biologics are produced using recombinant deoxyribonucleic acid technology. A drug is usually manufactured through chemical synthesis, and it's made by combining specific chemical ingredients in an ordered process. Biologics products are subjected to various laws and regulations that affect patenting, testing, safety, efficacy, and marketing.

Biologics products are isolated from natural sources like human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies. Pharmaceutical companies specializing in the event of several biopharmaceutical products to take care of the market position.

Market Dynamics:

Drivers:

Technological advancements in the sector

Robust research and development activities

Restraints:

Strict regulations for the R&D approval

Issues associated with infringement or agreement

Key Market Players:

Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi, Pfizer Inc., Merck & Co. Inc, Novo Nordisk A/S, and Johnson & Johnson Services Inc. are some of the prominent players in the global biologics market.

The market is segmented based on the below-mentioned segments:

On the Basis of Product Type: Revenue

o Monoclonal Antibodies

o Therapeutic Proteins

o Vaccines

o Antisense

o RNAi

On the Basis of Source: Revenue

o Microbial

o Mammalian

On The Basis of Region: Revenue

North America

- U.S.A
- Canada
- Mexico

Europe

- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

Asia Pacific

- China
- Japan
- India
- SEA
- Australia
- Rest Of APAC

South America

- Brazil
- Argentina
- Rest of South America

Middle East & Africa

- South Africa
- Saudi Arabia
- UAE
- Rest of MEA

Report Description

Year Consideration
- Base year – 2020
- Historic Year-2017-2019
- Forecast year- 2021 to 2028

The global biologics market will be based on revenue and volume. The study covers the market share for segments, countries, regions, and players.

The regions evaluated for the global biologics market are Europe, North America, Asia Pacific, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country-level.

The report provides an in-depth pricing analysis, value chain analysis, industry road map, and micro and macro factors.

The research report further provides the attractiveness of biologics and regions based on their growth rate (CAGR), market size, and attractiveness by analyzing present and future prospects to analyze market growth and development in the future.

Also, the study focuses on market-related driving forces, restraints, potential opportunities for the market, significant developments, and advancement that serve as a key potential for investors.

The study offers an extensive evaluation of Porter's five forces analysis, SWOT analysis, and PESTEL analysis to provide data and information related to the business.

Porter's five forces model is analyzed to understand the overall competitive scenario that prevails in the market. The SWOT analysis also identifies the positive as well as the negative characteristics of market development which influences the company’s growth and development to sustain and survive in the long run. The PESTEL analysis identifies the macro (external) forces affecting the organization.

The report includes a thorough analysis of the company profiles of major companies operating in the global biologics market and a comparative evaluation based on their business overviews, product offering, geographic presence, market share, business strategy, recent developments, product development & innovations, joint ventures, partnerships, mergers & acquisitions, expansions, SWOT analysis, and key financial information. It helps in evaluating the overall competition present in the market scenario.

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Full Name

Company Name

Designation/Position

Contact

Region/Country

Message

Kindly share your specific requirement (if any), so we can get back to you with a solution

TABLE OF CONTENTS
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. SCOPE OF THE STUDY
1.3. GEOGRAPHIC SCOPE
1.4. MARKET DEFINITION
1.5. CURRENCY CONSIDERATION
1.6. YEAR CONSIDERATION
2. RESEARCH METHODOLOGY AND ASSUMPTIONS
2.1. SECONDARY RESEARCH
2.2. PRIMARY RESEARCH
2.3. MARKET BREAKUP AND DATA TRIANGULATION
2.4. MARKET SIZE ESTIMATION
2.4.1. BOTTOM UP APPROACH
2.4.2. TOP DOWN APPROACH
2.5. ASSUMPTION
3. EXECUTIVE SUMMARY
3.1. KEY MARKET INSIGHTS
3.2. SEGMENTATION OUTLOOK
3.3. COMPANY OUTLOOK
4. PREMIUM INSIGHTS
4.1. IMPACT OF COVID-19 ON MARKET
4.2. INDUSTRY ROAD MAP
4.3. INDUSTRY TREND
4.4. INDUSTRY SWOT ANALYSIS
4.5. MARKET ATTRACTIVENESS ANALYSIS
4.5.1. MARKET ATTRACTIVENESS BY SEGMENTS
4.5.1.1. BIOLOGICS MARKET ATTENTIVENESS BY SOURCE
4.5.1.2. BIOLOGICS MARKET ATTENTIVENESS BY PRODUCT TYPE
4.5.2. MARKET ATTRACTIVENESS BY REGION
4.5.2.1. NORTH AMERICA BIOLOGICS MARKET ATTENTIVENESS BY COUNTRY
4.5.2.2. EUROPE BIOLOGICS MARKET ATTENTIVENESS BY COUNTRY
4.5.2.3. ASIA PACIFIC BIOLOGICS MARKET ATTENTIVENESS BY COUNTRY
4.5.2.4. SOUTH AMERICA BIOLOGICS MARKET ATTENTIVENESS BY COUNTRY
4.5.2.5. MIDDLE EAST AND AFRICA BIOLOGICS MARKET ATTENTIVENESS BY COUNTRY
4.6. PORTER’S FIVE FORCES ANALYSIS
4.6.1. THREAT OF NEW ENTRANTS
4.6.2. THREAT OF SUBSTITUTES
4.6.3. BARGAINING POWER OF SUPPLIERS
4.6.4. BARGAINING POWER OF BUYERS
4.6.5. INTENSITY OF COMPETITIVE RIVALRY
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH & DEVELOPMENT COMPANIES
4.7.2. RAW MATERIAL/ COMPONENT SUPPLIERS
4.7.3. PRODUCT MANUFACTURERS
4.7.4. DISTRIBUTORS AND RETAILERS
4.7.5. END-USER INDUSTRIES
4.7.6. POST-SALES SERVICE PROVIDERS
4.8. FACTORS AFFECTING THE MARKET
4.8.1. MACRO FACTORS AFFECTING THE MARKET
4.8.2. MICRO FACTORS AFFECTING THE MARKET
4.8.3. PESTEL ANALYSIS
4.9. YEAR ON YEAR GROWTH RATE OF BIOLOGICS
4.10. LIST OF SUPPLIERS
4.11. LIST OF BUYERS
4.12. COUNTRY LEVEL ANALYSIS
4.13. RULES AND REGULATION
5. MARKET DYNAMICS
5.1. MARKET DRIVERS
5.1.1. TECHNOLOGICAL ADVANCEMENTS IN THE SECTOR
5.1.2. ROBUST RESEARCH AND DEVELOPMENT ACTIVITIES
5.2. MARKET RESTRAINTS
5.2.1. STRICT REGULATIONS FOR THE R&D APPROVAL
5.2.2. ISSUES ASSOCIATED WITH INFRINGEMENT OR AGREEMENT
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
6. GLOBAL BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY PRODUCT TYPE - 2017-2028
6.1. KEY FINDINGS
6.2. MONOCLONAL ANTIBODIES
6.3. THERAPEUTIC PROTEINS
6.4. VACCINES
6.5. ANTISENSE
6.6. RNAI
7. GLOBAL BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY SOURCE - 2017-2028
7.1. KEY FINDINGS
7.2. MICROBIAL
7.3. MAMMALIAN
8. GLOBAL BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY REGIONAL - 2017-2028
8.1. KEY FINDINGS
8.2. NORTH AMERICA
8.3. EUROPE
8.4. ASIA PACIFIC
8.5. SOUTH AMERICA
8.6. MIDDLE EAST & AFRICA
9. NORTH AMERICA BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
9.1. BY COUNTRY
9.1.1. U.S.
9.1.2. CANADA
9.1.3. MEXICO
10. EUROPE BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
10.1. BY COUNTRY
10.1.1. GERMANY
10.1.2. U.K.
10.1.3. FRANCE
10.1.4. ITALY
10.1.5. SPAIN
10.1.6. SWEDEN
10.1.7. BELGIUM
10.1.8. TURKEY
10.1.9. RUSSIA
10.1.10. POLAND
10.1.11. SWITZERLAND
10.1.12. NETHERLANDS
10.1.13. REST OF EUROPE
11. ASIA PACIFIC BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
11.1. BY COUNTRY
11.1.1.1. JAPAN
11.1.1.2. CHINA
11.1.1.3. INDIA
11.1.1.4. AUSTRALIA
11.1.1.5. SOUTH KOREA
11.1.1.6. MALAYSIA
11.1.1.7. INDONESIA
11.1.1.8. VIETNAM
11.1.1.9. NEW ZEALAND
11.1.1.10. PHILIPPINES
11.1.1.11. TAIWAN
11.1.1.12. SINGAPORE
11.1.1.13. REST OF ASIA-PACIFIC
12. SOUTH AMERICA BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
12.1. BY COUNTRY
12.1.1.1. BRAZIL
12.1.1.2. ARGENTINA
12.1.1.3. CHILE
12.1.1.4. COLOMBIA
12.1.1.5. REST OF SOUTH AMERICA
13. MIDDLE EAST & AFRICA BIOLOGICS MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
13.1. BY COUNTRY
13.1.1.1. SOUTH AFRICA
13.1.1.2. U.A.E.
13.1.1.3. SAUDI ARABIA
13.1.1.4. REST OF MIDDLE EAST AND AFRICA
14. COMPETITIVE LANDSCAPE
14.1. MARKET SHARE OF KEY PLAYERS IN POWER TOOL MARKET
14.1.1. GLOBAL MARKET SHARE ANALYSIS
14.1.2. NORTH AMERICA MARKET SHARE ANALYSIS
14.1.3. EUROPE MARKET SHARE ANALYSIS
14.1.4. ASIA PACIFIC MARKET SHARE ANALYSIS
14.1.5. SOUTH AMERICA MARKET SHARE ANALYSIS
14.1.6. MIDDLE EAST & AFRICA MARKET SHARE ANALYSIS
14.2. LEADERSHIP MAPPING
14.2.1. VISIONARY PLAYERS
14.2.2. INNOVATORS PLAYERS
14.2.3. DYNAMIC DIFFERENTIATORS
14.2.4. EMERGING COMPANIES
14.3. COMPETITIVE SCENARIO AND TRENDS
14.3.1. MERGERS & ACQUISITIONS
14.3.2. PRODUCT LAUNCHES AND DEVELOPMENTS
14.3.3. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
14.3.4. EXPANSIONS
15. COMPANY PROFILES
15.1.1. ELI LILLY & COMPANY
15.1.1.1. COMPANY OVERVIEW
15.1.1.2. COMPANY SNAPSHOT
15.1.1.3. FINANCIAL ANALYSIS
15.1.1.3.1. REVENUE ANALYSIS
15.1.1.3.2. SALES ANALYSIS
15.1.1.3.3. PRICE ANALYSIS
15.1.1.3.4. MARGIN ANALYSIS
15.1.1.4. GEOGRAPHICAL PRESENCE
15.1.1.4.1. NORTH AMERICA
15.1.1.4.2. EUROPE
15.1.1.4.3. ASIA PACIFIC
15.1.1.4.4. SOUTH AMERICA
15.1.1.4.5. MIDDLE EAST & AFRICA
15.1.1.5. PRODUCT PORTFOLIO
15.1.1.6. SWOT ANALYSIS
15.1.1.7. RECENT DEVELOPMENT
15.1.2. SAMSUNG BIOLOGICS
15.1.3. F HOFFMAN LA ROCHE
15.1.4. CELLTRION
15.1.5. ADDGENE
15.1.6. AMGEN
15.1.7. ABBVIE INC.
15.1.8. SANOFI
15.1.9. PFIZER INC.
15.1.10. MERCK & CO. INC
15.1.11. NOVO NORDISK A/S
15.1.12. JOHNSON & JOHNSON SERVICES INC.
16. STRATEGIC RECOMMENDATIONS
LIST OF TABLE
1. RESEARCH ASSUMPTION
2. COVID-19 IMPACT ON MARKET
3. MAJOR DEVELOPMENTS BY VARIOUS COMPANIES
4. GLOBAL BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
5. GLOBAL MONOCLONAL ANTIBODIES BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
6. GLOBAL THERAPEUTIC PROTEINS BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
7. GLOBAL VACCINES BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
8. GLOBAL ANTISENSE BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
9. GLOBAL RNAI BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
10. GLOBAL BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
11. GLOBAL MICROBIAL BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
12. GLOBAL MAMMALIAN BIOLOGICS MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
13. GLOBAL BIOLOGICS MARKET, BY NORTH AMERICA, 2017–2028 REVENUE (USD MILLION)
14. NORTH AMERICA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
15. NORTH AMERICA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
16. U.S. BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
17. U.S. BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
18. CANADA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
19. CANADA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
20. MEXICO BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
21. MEXICO BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
22. EUROPE BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
23. EUROPE BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
24. GERMANY BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
25. GERMANY BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
26. FRANCE BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
27. FRANCE BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
28. U.K. BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
29. U.K. BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
30. ITALY BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
31. ITALY BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
32. SPAIN BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
33. SPAIN BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
34. SWEDEN BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
35. SWEDEN BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
36. BELGIUM BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
37. BELGIUM BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
38. TURKEY BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
39. TURKEY BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
40. RUSSIA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
41. RUSSIA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
42. POLAND BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
43. POLAND BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
44. SWITZERLAND BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
45. SWITZERLAND BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
46. NETHERLANDS BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
47. NETHERLANDS BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
48. ASIA PACIFIC BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
49. ASIA PACIFIC BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
50. JAPAN BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
51. JAPAN BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
52. CHINA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
53. CHINA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
54. INDIA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
55. INDIA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
56. AUSTRALIA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
57. AUSTRALIA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
58. SOUTH KOREA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
59. SOUTH KOREA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
60. INDONESIA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
61. INDONESIA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
62. VIETNAM BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
63. VIETNAM BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
64. NEW ZEALAND BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
65. NEW ZEALAND BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
66. PHILIPPINES BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
67. PHILIPPINES BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
68. TAIWAN BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
69. TAIWAN BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
70. SINGAPORE BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
71. SINGAPORE BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
72. SOUTH AMERICA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
73. SOUTH AMERICA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
74. BRAZIL BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
75. BRAZIL BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
76. ARGENTINA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
77. ARGENTINA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
78. CHILE BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
79. CHILE BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
80. COLOMBIA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
81. COLOMBIA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
82. MIDDLE EAST AND AFRICA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
83. MIDDLE EAST AND AFRICA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
84. UAE BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
85. UAE BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
86. SOUTH AFRICA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
87. SOUTH AFRICA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
88. SAUDI ARABIA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
89. SAUDI ARABIA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)
90. REST OF MEA BIOLOGICS MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
91. REST OF MEA BIOLOGICS MARKET, BY SOURCE, 2017–2028 REVENUE (USD MILLION)

LIST OF FIGURE
1. RESEARCH DESIGN
2. SCOPE OF THE STUDY
3. GEOGRAPHIC SCOPE
4. CURRENCY CONSIDERATION
5. YEAR CONSIDERATION
6. MARKET ESTIMATION
7. RESEARCH METHODOLOGY
8. DATA TRIANGULATION
9. COVID-19 IMPACT ON MARKET
10. GLOBAL BIOLOGICS MARKET ATTRACTIVENESS ANALYSIS BY SOURCE
11. GLOBAL BIOLOGICS MARKET ATTRACTIVENESS ANALYSIS BY PRODUCT TYPE
12. GLOBAL BIOLOGICS MARKET ATTRACTIVENESS ANALYSIS BY REGION
13. GLOBAL BIOLOGICS MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
14. GLOBAL BIOLOGICS MARKET: DYNAMICS
15. PESTEL ANALYSIS
16. SWOT ANALYSIS
17. GLOBAL BIOLOGICS MARKET ANALYSIS BY REGION
18. GLOBAL BIOLOGICS MARKET ANALYSIS BY SOURCE
19. GLOBAL BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE
20. GLOBAL BIOLOGICS MARKET ANALYSIS BY NORTH AMERICA
21. GLOBAL BIOLOGICS MARKET ANALYSIS BY EUROPE
22. GLOBAL BIOLOGICS MARKET ANALYSIS BY ASIA PACIFIC
23. GLOBAL BIOLOGICS MARKET ANALYSIS BY SOUTH AMERICA
24. GLOBAL BIOLOGICS MARKET ANALYSIS BY MIDDLE EAST & AFRICA
25. GLOBAL BIOLOGICS MARKET SHARE BY COMPANY (2020)
26. NORTH AMERICA BIOLOGICS MARKET SHARE BY COMPANY (2020)
27. EUROPE BIOLOGICS MARKET SHARE BY COMPANY (2020)
28. ASIA PACIFIC BIOLOGICS MARKET SHARE BY COMPANY (2020)
29. SOUTH AMERICA BIOLOGICS MARKET SHARE BY COMPANY (2020)
30. MIDDLE EAST & AFRICA BIOLOGICS MARKET SHARE BY COMPANY (2020)